These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 23425111

  • 1. Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm.
    Park DI, Shin HM, Lee SY, Lew H.
    Acta Ophthalmol; 2013 Mar; 91(2):e108-12. PubMed ID: 23425111
    [Abstract] [Full Text] [Related]

  • 2. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.
    Lu R, Huang R, Li K, Zhang X, Yang H, Quan Y, Li Q.
    Am J Ophthalmol; 2014 Mar; 157(3):591-7.e1-2. PubMed ID: 24269849
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye.
    Horwath-Winter J, Bergloeff J, Floegel I, Haller-Schober EM, Schmut O.
    Br J Ophthalmol; 2003 Jan; 87(1):54-6. PubMed ID: 12488263
    [Abstract] [Full Text] [Related]

  • 4. Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm.
    Gunes A, Demirci S, Koyuncuoglu HR, Tok L, Tok O.
    Cornea; 2015 Aug; 34(8):906-10. PubMed ID: 26075455
    [Abstract] [Full Text] [Related]

  • 5. Characteristics of tear abnormalities associated with benign essential blepharospasm and amelioration by means of botulinum toxin type A treatment.
    Hosotani Y, Yokoi N, Okamoto M, Ishikawa H, Komuro A, Kato H, Mimura O, Gomi F.
    Jpn J Ophthalmol; 2020 Jan; 64(1):45-53. PubMed ID: 31823132
    [Abstract] [Full Text] [Related]

  • 6. Tear osmolarity, dry eye syndrome, blepharospasm and botulinum neurotoxin.
    Girard B, de Saint Sauveur G.
    J Fr Ophtalmol; 2021 Dec; 44(10):1553-1559. PubMed ID: 34756743
    [Abstract] [Full Text] [Related]

  • 7. Ocular Surface Metrics in Blepharospasm Patients After Treatment With Botulinum Toxin Injections.
    Yabumoto C, Osaki MH, Osaki T, Gameiro GR, Campos M, Osaki TH.
    Ophthalmic Plast Reconstr Surg; 2021 Dec; 39(5):475-478. PubMed ID: 36928309
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm : BTX improves dry eye in patients with BEB.
    Isshiki Y, Ishikawa H, Mimura O.
    Jpn J Ophthalmol; 2016 Nov; 60(6):486-491. PubMed ID: 27503401
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm.
    Ho RW, Fang PC, Chao TL, Chien CC, Kuo MT.
    Sci Rep; 2018 May 30; 8(1):8367. PubMed ID: 29849166
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of eyelid botulinum toxin injection on lacrimal drainage.
    Sahlin S, Chen E, Kaugesaar T, Almqvist H, Kjellberg K, Lennerstrand G.
    Am J Ophthalmol; 2000 Apr 30; 129(4):481-6. PubMed ID: 10764857
    [Abstract] [Full Text] [Related]

  • 18. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH, Cetinkaya A, Kulwin DR.
    Clin Exp Ophthalmol; 2014 Apr 30; 42(3):254-61. PubMed ID: 23844601
    [Abstract] [Full Text] [Related]

  • 19. Tear meniscus measurement in nasolacrimal duct obstruction patients with Fourier-domain optical coherence tomography: novel three-point capture method.
    Park DI, Lew H, Lee SY.
    Acta Ophthalmol; 2012 Dec 30; 90(8):783-7. PubMed ID: 21726426
    [Abstract] [Full Text] [Related]

  • 20. Correlations among ocular surface temperature difference value, the tear meniscus height, Schirmer's test and fluorescein tear film break up time.
    Su TY, Ho WT, Lu CY, Chang SW, Chiang HK.
    Br J Ophthalmol; 2015 Apr 30; 99(4):482-7. PubMed ID: 25297654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.